22 Oct 2025

"Jardine Strategic to Acquire Remaining Shares of Mandarin Oriental for $3.35 Each"

"Slaughter and May is advising the Transaction Committee of Mandarin Oriental International Limited on a cash acquisition by Jardine Strategic Limited, which aims to acquire the remaining 11.96% of shares it does not own. The acquisition, announced on October 17, 2025, will allow independent shareholders to receive US$3.35 per share, including a special dividend of US$0.60. This acquisition is linked to the sale of property to Alibaba Group and Ant Group for US$925 million. The total value of Mandarin Oriental is estimated at US$4.2 billion, with completion expected by February 2026, pending shareholder approval and court sanction."

Slaughter and May is advising the Mandarin Oriental International Limited Transaction Committee in connection with the recommended cash acquisition by Jardine Strategic Limited, a wholly-owned subsidiary of Jardine Matheson Holdings Limited. The transaction involves Jardine Strategic acquiring the remaining 11.96 percent of Mandarin Oriental’s total issued share capital that it does not already own. The acquisition, announced on 17 October 2025, will be executed through a scheme of arrangement under Bermuda law. If completed, independent shareholders of Mandarin Oriental will receive a total value of US$3.35 in cash per share, which includes US$2.75 in cash and a special dividend of US$0.60. This special dividend is contingent upon the completion of the sale of the top thirteen floors of One Causeway Bay to Alibaba Group and Ant Group for US$925 million, also announced on the same date. The entire transaction is expected to finalize by the end of February 2026, pending shareholder approval and court sanction. The legal team from Slaughter and May involved in this transaction includes: - Jason Webber, Partner - Ben Heron, Partner - Claire Jackson, Partner - Stephanie Courtice, Counsel - Andy Goodworth, Associate - Jason Hui, Associate - Phoebe Harris, Associate - Tean Manser, Trainee
Read the full story

Register for free to access daily news.

Register Free
We use cookies to improve your experience, analyze traffic, and serve targeted ads. Read our Cookie Policy.

Cookie Preferences

Customize your cookie settings. Necessary cookies are always enabled.

Strictly Necessary

Required for the website to function (e.g. login, security).

Analytics & Statistics

Help us understand how visitors interact with the website.

Marketing & Ads

Used to deliver relevant ads and track effectiveness.